Magnesium to prevent new atrial fibrillation in ICU patients
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether giving magnesium can lower the chance of developing new irregular heartbeat (atrial fibrillation) in critically ill adults in the ICU. If you are at risk but do not already have this rhythm issue, magnesium may help prevent it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult age 18 or older.
- Be in an ICU now with continuous heart monitoring and at least one ICU need like breathing support, strong medicines to support blood pressure, or a recent cardiac arrest.
- Breathing support or heart-support medicines must be expected to last more than 24 hours.
- You should NOT already have atrial fibrillation at the time you would enroll.
- You must not have already received more than 18 hours of ICU breathing/heart-support treatments before enrollment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving magnesium as part of a standard hospital protocol can lower the risk of irregular heartbeat and improve survival in patients admitted to the intensive care unit.
This trial looks at people who develop a new irregular heart rhythm called atrial fibrillation while in the intensive care unit (ICU). It tests an approach to help with that condition after critical illness, aiming to improve outcomes for those affected.
This study tests whether giving a short course of a medication called amiodarone after heart surgery helps prevent or control new irregular heartbeats (atrial fibrillation) and helps you leave the hospital sooner.
This trial tests whether giving a higher dose of magnesium (4 grams) compared to a lower dose (2 grams) or a placebo can help control a fast heart rate during atrial fibrillation. It may help patients who are already receiving diltiazem.
This study tests whether adding magnesium to the standard heart-rate medicine metoprolol helps control a fast heartbeat better in people with atrial fibrillation. It may help slow the heart rate more quickly and reduce symptoms.
This study tests if giving magnesium soon after a cardiac arrest can protect the brain and improve recovery. It is for adults who have been brought back to life after a heart stoppage.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.